Ma, L J <br/><br/>
Peroxisome proliferator-activated receptor-gamma agonist troglitazone protects against nondiabetic glomerulosclerosis in rats.  [electronic resource] 

 -  Kidney international  May 2001 
 - 1899-910 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0085-2538 
<br/><br/><label>Standard No.: </label>10.1046/j.1523-1755.2001.0590051899.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antihypertensive Agents--pharmacology<br/>Base Sequence<br/>Chromans--pharmacology<br/>DNA Primers--genetics<br/>Disease Models, Animal<br/>Glomerulosclerosis, Focal Segmental--etiology<br/>Hypoglycemic Agents--pharmacology<br/>Insulin Resistance<br/>Kidney--pathology<br/>Lipids--blood<br/>Macrophages--pathology<br/>Male<br/>Nephrectomy<br/>Plasminogen Activator Inhibitor 1--genetics<br/>RNA, Messenger--genetics<br/>Rats<br/>Rats, Sprague-Dawley<br/>Receptors, Cytoplasmic and Nuclear--agonists<br/>Thiazoles--pharmacology<br/>Thiazolidinediones<br/>Transcription Factors--agonists<br/>Transforming Growth Factor beta--genetics<br/>Troglitazone